MACAU DAILY TIMES 澳門每日時報

Top Menu

  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia

Main Menu

  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia
logo
FOUNDER & PUBLISHER Kowie Geldenhuys
EDITOR-IN-CHIEF Paulo Coutinho
Macau,

MACAU DAILY TIMES 澳門每日時報

  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Al Dhaheri beats Colnaghi and qualifies on pole

  • Heinrich domination continues at Qualification Race

  • Urrutia wins Race 1 and keeps championship hopes alive

  • Kenzo Craigie wins drama-packed Qualification Race

  • Damon Chan wins interrupted race

  • Hickman shatters lap record for Motorcycle Grand Prix title

Business
Home›Business›Late audits halt trading in Morgan Stanley-backed stocks

Late audits halt trading in Morgan Stanley-backed stocks

By -
Wednesday, April 1, 2015
149
0
The Tianhe Fuxin flourochemical plant in Jinzhou, China. Two Morgan Stanley-backed Chinese companies will not be filing their financial statements on time and have stopped trading in their stocks

The Tianhe Fuxin flourochemical plant in Jinzhou, China. Two Morgan Stanley-backed Chinese companies will not be filing their financial statements on time and have stopped trading in their stocks

Two major companies in a prominent USD1.4 billion Asia investment fund managed by New York banking giant Morgan Stanley unexpectedly told securities regulators they will not file their financial statements on time and froze trading in their stocks, actions generally considered to be cause for concern.
The publicly traded companies, Tianhe Chemicals Group Ltd. and Sihuan Pharmaceutical Holdings Group Ltd., separately announced late last week that they would be unable to meet Hong Kong Stock Exchange deadlines because auditors have not yet signed off on their financials. Both companies pledged to cooperate with the auditors.
Tianhe and Sihuan are valued at USD3.7 billion and $6 billion, respectively. They are among 16 companies that comprise a private equity fund managed by Morgan Stanley & Co. LLC, known as Morgan Stanley Private Equity Asia Three, or MSPEA III. An Australian and an Indian company owned by that fund have already failed amid criminal and civil fraud allegations.
A spokesman for Morgan Stanley, Nick Footitt, declined to comment on the missed filings. A Tianhe spokeswoman also declined comment. Sihuan responded to some questions in an emailed statement but said only that the auditors needed more time and that the company was operating as usual.
The twin filing delays raise uncomfortable questions for Morgan Stanley, which picked the companies from obscurity then promoted them as multibillion-dollar growth stories.
“This is not something an auditing firm would do lightly,” said Paul Gillis, a former Partner for PricewaterhouseCoopers LLP in China who now teaches accounting at Peking University. “There are only two reasonable explanations for being late. One is management incompetence. Two is they’re fighting with the auditors. And neither one of those is good.”
Tianhe and Sihuan could eventually receive a clean bill of health, although announcements about earnings delays due to unfinished audits are generally regarded as portending bad news. Any material problems that led to the delay would have to be disclosed once the companies file their financials.
As U.S. investors increasingly consider Chinese stocks, they rely on investment banks like Morgan Stanley to keep troubled Chinese companies from reaching the market.
Morgan Stanley’s private equity team has promised investors it would perform rigorous due diligence and take stakes only in companies where it could exert influence or control. As part of its investments in the two companies, the same Morgan Stanley executive director, Homer Sun, received a seat on each company’s board.
Tianhe Chemicals, the largest investment in the Morgan Stanley fund, was the subject of an investigation by The Associated Press last year and already had its stock frozen last year amid allegations that the company overstated the scale and sophistication of its business.
Sihuan describes itself as one of the largest producers of drugs sold to Chinese hospitals. It announced in October that it was collaborating with the Chinese military on a new Ebola drug treatment called jk-05. But a scientist for the World Health Organization, Martin Friede, told the AP that the company has declined WHO’s repeated requests to provide information about the molecular structure of the drug. The World Health Organization coordinates clinical trials on Ebola drugs, and Friede described sharing such information as standard procedure.
“I would imagine that if it was really novel, and if there was really good information, they would want to share it,” Friede told the AP. “So, connect the dots.”
Sihuan did not say why it had not provided information about the drug to the WHO. A spokeswoman said the drug is “a new molecular entity based on Favipiravir,” an existing experimental Ebola drug created by Japan’s Fujifilm Holdings Corp. Sihuan has filed for a patent on its improved version of the drug that it expects can be administered orally or via injection, the spokeswoman said.
China’s Center for Disease Control told the WHO that the Chinese drug is identical to Favipiravir, Friede said.
Fujifilm Holdings spokeswoman Kana Matsumoto told the AP that her company also questioned whether Sihuan’s drug was new.
“We have already notified the Chinese Embassy that Avigan (another name for Favipiravir) is protected by a substance patent, application patent and process patent in China,” she said.
Tianhe was the subject of significant public scrutiny over its financials. In September, a shadowy group tied to speculators betting against Tianhe’s stock published allegations that the company had overstated its business in a Morgan Stanley-led public offering just a few months earlier.
An AP investigation corroborated many discrepancies. Tianhe said records cited by AP were outdated and disputed other findings. But the controversy drew public notice from its auditor, Deloitte Touche Tohmatsu Ltd., which Gillis said would have been expected to put extra emphasis on its next audit process.
“The auditors have had plenty of time to look into the allegations and dismiss them,” Gillis said. “In this case, everybody would have been paying attention.” Jeff Horwitz, Washington, AP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Print (Opens in new window) Print

Like this:

Like Loading…

Related

Previous Article

Corporate Bits: Private dinner “the west lake ...

Next Article

Traditional Chinese medicine seen as ‘key’ area

Related articles More from author

  • Business

    Diesel cars to die out in Tesla-like future, EU regulator says

    Monday, May 28, 2018
    By -
  • BusinessMacau

    Ask the Vet | 5 Subtle 
Canine 
Cancer 
Symptoms
 Worth 
a
 Trip
 to the
Vet

    Monday, May 15, 2017
    By -
  • Business

    Former Twitter executives sue Musk over firings, seek more than $128m in severance

    Wednesday, March 6, 2024
    By -
  • Business

    Fed Chair to speak today | Dollar rally fades away before Yellen as european stocks retreat

    Friday, August 26, 2016
    By -
  • Business

    NASCAR data deal could lead to more bets

    Monday, May 6, 2019
    By -
  • Business

    Corporate Bits | Three-star Michelin guest chef Thomas Bühner at Vida Rica

    Tuesday, April 21, 2015
    By -

Leave a reply Cancel reply

You must be logged in to post a comment.

  • Asia-Pacific

    South Korean manufacturer of Russian vaccine braces for complications

  • Business

    Singapore luxury home prices set to recover, Guocoland says

  • tTunes

    Larry Campbell & Teresa Williams show rootsy range

DAILY EDITION

Friday, November 20, 2026 – edition no. 5079
Friday, November 20, 2026 – edition no. 5079

Greater Bay

MDT MACAU GRAND PRIX SPECIAL

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    

Timeline

  • Saturday, November 21, 2026

    Al Dhaheri beats Colnaghi and qualifies on pole

  • Saturday, November 21, 2026

    Heinrich domination continues at Qualification Race

  • Saturday, November 21, 2026

    Urrutia wins Race 1 and keeps championship hopes alive

  • Saturday, November 21, 2026

    Kenzo Craigie wins drama-packed Qualification Race

  • Saturday, November 21, 2026

    Damon Chan wins interrupted race

  • Saturday, November 21, 2026

    Hickman shatters lap record for Motorcycle Grand Prix title

  • Friday, November 20, 2026

    China-Russia-US Heads of State Declaration toward Peace

  • Friday, November 20, 2026

    APEC leaders back Shenzhen trade agenda as Xi meets Trump and Putin

  • Friday, November 20, 2026

    Lawmakers call for stronger building management and measures to stabilize property market

  • Friday, November 20, 2026

    Bill sets five grounds for dissolution of civil associations

Extra Times

Drive InExtra Times

‘Madden’ biopic can’t find a playbook to stick with

Which play to run is a question that can bedevil any football coach, and it’s also what dooms David O. Russell’s fumbled biopic “Madden.” “Madden” may sport an all-star cast ...
  • Juksunchae: A Study in Precision and Contemporary Korean Cuisine

    By Irene Sam, MDT
    Friday, November 20, 2026
  • Reframing the “Hundreds of Flavors”: Chiang and Ho at Zi Yat Heen

    By -
    Friday, November 20, 2026
  • Three chefs. One horizon. Six Michelin stars

    By Irene Sam, MDT
    Friday, November 13, 2026
  • James Gray delivers a milestone crime drama in ‘Paper Tiger’

    By MDT/AP
    Friday, November 13, 2026
  • Recent

  • Popular

  • Al Dhaheri beats Colnaghi and qualifies on pole

    By Renato Marques, MDT
    Saturday, November 21, 2026
  • Heinrich domination continues at Qualification Race

    By Renato Marques, MDT
    Saturday, November 21, 2026
  • Urrutia wins Race 1 and keeps championship hopes alive

    By Renato Marques, MDT
    Saturday, November 21, 2026
  • Kenzo Craigie wins drama-packed Qualification Race

    By Renato Marques, MDT
    Saturday, November 21, 2026
  • Damon Chan wins interrupted race

    By Renato Marques, MDT
    Saturday, November 21, 2026
  • Hickman shatters lap record for Motorcycle Grand Prix title

    By Times Reporter
    Saturday, November 21, 2026
  • China-Russia-US Heads of State Declaration toward Peace

    By XINHUA
    Friday, November 20, 2026
  • Canidrome may have its days numbered, decision in ‘one or two months’

    By Paulo Coutinho, MDT
    Thursday, May 26, 2016
  • Animal Welfare | Macau: Anima slams Canidrome management for avoiding debate

    By -
    Wednesday, May 4, 2016
  • Editorial | Canidoomed

    By Paulo Coutinho, MDT
    Wednesday, June 1, 2016
  • Animal Welfare | Canidrome presented with ultimatum: close or move

    By Daniel Beitler, MDT
    Friday, July 22, 2016
  • Australia regulator cracks down on alleged exportation of dogs to Macau

    By Paulo Coutinho, MDT
    Friday, June 10, 2016
  • Animal rights | Canidrome: Anima in fresh airline negotiations as Canidrome closure looks more likely

    By Daniel Beitler, MDT
    Friday, May 27, 2016
  • USE OF ENGLISH IN MACAU | A ‘de facto’ official language

    By Catarina Pinto
    Monday, July 6, 2015
  • Contact our Administrator
  • Contact our Editor-in-Chief
  • Contacts
  • Our Team
  • Privacy Policy
  • Terms and Conditions
  • Editorial Statute
  • Code of Ethics
COPYRIGHT © MACAU DAILY TIMES 2008-2026. ALL RIGHTS RESERVED
MACAU DAILY TIMES
  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia
Loading Comments...

You must be logged in to post a comment.

%d